Unaudited Condensed Consolidated Balance Sheets - USD ($) $ in Thousands		Mar. 31, 2022	Dec. 31, 2021	Jun. 30, 2021
Current assets:
Cash and cash equivalents		$ 97,839		$ 116,369
Restricted cash		205		560
Accounts receivable, net of allowance for credit losses of $1,058 and $1,048 as of March 31, 2022 and June 30, 2021, respectively	[1]	89,295		85,360
Inventories		137,519		125,929
Prepaid expenses and other current assets	[2]	21,987		21,547
Deferred cost of revenue		351		3,008
Total current assets		347,196		352,773
Property and equipment, net		12,220		12,332
Investment in joint venture		14,251		15,935
Operating lease right-of-use assets, net		17,851		22,522
Goodwill		58,000		57,960
Intangible assets, net		286		435
Restricted cash		1,244		1,272
Other assets		18,388		16,869
Total assets		469,436		480,098
Current liabilities:
Accounts payable		32,364		19,467
Accrued compensation		25,461		26,865
Operating lease liabilities, current		8,351		8,169
Other accrued liabilities		26,018		27,471
Customer advances		24,363		24,937
Deferred revenue		76,732		81,660
Short-term debt		8,051		3,790
Total current liabilities		201,340		192,359
Long-term liabilities:
Operating lease liabilities, non-current		11,929		17,441
Long-term other liabilities		6,812		7,766
Deferred revenue		24,550		23,685
Long-term debt		173,196		170,007
Total liabilities		417,827		411,258
Commitments and contingencies (Note 9)
Stockholders' equity:
Common stock, $0.001 par value; authorized: 200,000,000 shares as of March 31, 2022 and June 30, 2021, respectively; issued and outstanding: 92,802,213 and 90,821,661 shares at March 31, 2022 and June 30, 2021, respectively		93		91
Additional paid-in-capital		539,383		554,680
Accumulated other comprehensive income		1,203		2,093
Accumulated deficit		(489,070)		(488,024)
Total stockholders' equity		51,609	$ 50,994	68,840
Total liabilities and stockholders' equity		$ 469,436		$ 480,098

[1] Includes trade receivable from the China joint venture, an equity method investment of $24,146 and $8,822 at March 31, 2022 and June 30, 2021, respectively. See Note 14.

[2] Includes other receivable from the China joint venture, an equity method investment of $616 and $187 at March 31, 2022 and June 30, 2021, respectively.